Factors influencing MR changes associated with sacral injury after high-intensity focused ultrasound ablation of uterine fibroids

References

• Cho JY, Kim SH, Kim SY, et al. Efficacy and safety of daily repeated sonographically guided high-intensity focused ultrasound treatment of uterine fibroids: preliminary study. J Ultrasound Med. 2013;32:397–406.
   PubMed Web of Science ®Google Scholar
• Zhang W, He M, Huang G, et al. A comparison of ultrasound-guided high intensity focused ultrasound for the treatment of uterine fibroids in patients with an anteverted uterus and a retroverted uterus. Int J Hyperthermia. 2016;32:623–629.
   PubMed Web of Science ®Google Scholar
• Yang Z, Zhang Y, Zhang R, et al. A case-control study of high-intensity focused ultrasound combined with sonographically guided intratumoral ethanol injection in the treatment of uterine fibroids. J Ultrasound Med. 2014;33:657–665.
   PubMed Web of Science ®Google Scholar
• Zhao WP, Chen JY, Chen WZ. Effect of biological characteristics of different types of uterine fibroids, as assessed with T2-weighted magnetic resonance imaging, on ultrasound-guided high-intensity focused ultrasound ablation. Ultrasound Med Biol. 2015;41:423–431.
   PubMed Web of Science ®Google Scholar
• Chen Y, Jiang J, Zeng Y, et al. Effects of a microbubble ultrasound contrast agent on high-intensity focused ultrasound for uterine fibroids: a randomised controlled trial. Int J Hyperthermia. 2018;1–5.
   PubMed Web of Science ®Google Scholar
• Lee JS, Hong GY, Lee KH, et al. Changes in anti-müllerian hormone levels as a biomarker for ovarian reserve after ultrasound-guided high-intensity focused ultrasound treatment of adenomyosis and uterine fibroid. BJOG: Int J Obstet Gy. 2017;124:18–22.
   PubMed Web of Science ®Google Scholar
• Kim YS, Kim TJ, Lim HK, et al. Preservation of the endometrial enhancement after magnetic resonance imaging-guided high-intensity focused ultrasound ablation of submucosal uterine fibroids. Eur Radiol. 2017;27:3956–3965.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Yue Y, Shui L, et al. Ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation for the treatment of patients with adenomyosis and prior abdominal surgical scars: a retrospective study. Int J Hyperthermia. 2015;31:777–783.
   PubMed Web of Science ®Google Scholar
• Kim YS, Lim HK, Rhim H. Magnetic resonance imaging-guided high-intensity focused ultrasound ablation of uterine fibroids: effect of bowel interposition on procedure feasibility and a unique bowel displacement technique. PLoS One. 2016;11:e0155670.
   PubMed Web of Science ®Google Scholar
• Peng S, Zhang L, Hu L, et al. Factors influencing the dosimetry for high-intensity focused ultrasound ablation of uterine fibroids: a retrospective study. Medicine. 2015;94:e650.
   PubMed Web of Science ®Google Scholar
• Gong C, Yang B, Shi Y, et al. Factors influencing the ablative efficiency of high intensity focused ultrasound (HIFU) treatment for adenomyosis: a retrospective study. Int J Hyperthermia. 2016;32:496–503.
   PubMed Web of Science ®Google Scholar
• Wang X, Qin J, Wang L, et al. Effect of high-intensity focused ultrasound on sexual function in the treatment of uterine fibroids: comparison to conventional myomectomy. Arch Gynecol Obstet. 2013;288:851–858.
   PubMed Web of Science ®Google Scholar
• Zhao WP, Chen JY, Zhang L, et al. Feasibility of ultrasound-guided high intensity focused ultrasound ablating uterine fibroids with hyperintense on T2-weighted MR imaging. Eur J Radiol. 2013;82:e43–e49.
   PubMed Web of Science ®Google Scholar
• Cardella JF, Kundu S, Miller DL, et al. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2009;20:S189–S191.
   PubMed Web of Science ®Google Scholar
• Leung JH, Yu SC, Cheung EC, et al. Safety and efficacy of sonographically guided high-intensity focused ultrasound for symptomatic uterine fibroids: preliminary study of a modified protocol. J Ultrasound Med. 2014;33:1811–1818.
   PubMed Web of Science ®Google Scholar
• Feng Y, Hu L, Chen W, et al. Safety of ultrasound-guided high-intensity focused ultrasound ablation for diffuse adenomyosis: a retrospective cohort study. Ultrason Sonochem. 2017;36:139–145.
   PubMed Web of Science ®Google Scholar
• Chen R, Keserci B, Bi H, et al. The safety and effectiveness of volumetric magnetic resonance-guided high-intensity focused ultrasound treatment of symptomatic uterine fibroids: early clinical experience in China. J Ther Ultrasound. 2016;4:27.
   PubMed Web of Science ®Google Scholar
• Keserci B, Duc NM. The role of T1 perfusion-based classification in predicting the outcome of magnetic resonance-guided high-intensity focused ultrasound treatment of adenomyosis. Int J Hyperthermia. 2018;34:306–314.
   PubMed Web of Science ®Google Scholar
• Jeong JH, Hong GP, Kim YR, et al. Clinical consideration of treatment to ablate uterine fibroids with magnetic resonance imaging-guided high intensity focused ultrasound (MRgFUS): sonalleve. J Menopausal Med. 2016;22:94–107.
   PubMedGoogle Scholar
• Zhang X, Zou M, Zhang C, et al. Effects of oxytocin on high intensity focused ultrasound (HIFU) ablation of adenomysis: a prospective study. Eur J Radiol. 2014;83:1607–1611.
   PubMed Web of Science ®Google Scholar
• Jiang N, Xie B, Zhang X, et al. Enhancing ablation effects of a microbubble-enhancing contrast agent ("SonoVue") in the treatment of uterine fibroids with high-intensity focused ultrasound: a randomized controlled trial. Cardiovasc Intervent Radiol. 2014;37:1321–1328.
   PubMed Web of Science ®Google Scholar
• Isern J, Pessarrodona A, Rodriguez J, et al. Using microbubble sonographic contrast agent to enhance the effect of high intensity focused ultrasound for the treatment of uterine fibroids. Ultrason Sonochem. 2015;27:688–693.
   PubMed Web of Science ®Google Scholar
• Wang X, Qin J, Chen J, et al. The effect of high-intensity focused ultrasound treatment on immune function in patients with uterine fibroids: preliminary study. Int J Hyperthermia. 2013;29:225–233.
   PubMed Web of Science ®Google Scholar